Overbaugh Jason G.

SEC source: 0001096906-21-002161 · primary_doc.xml · derivative · entry 5

Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,252

Underlying: Class C Common Stock · 28,252 shares

Expires 2028-11-30

F5 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F5 · shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F5 · price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F5 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F5 · balance_after: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

SEC source: 0001096906-21-002160 · primary_doc.xml · derivative · entry 8

Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,252

Underlying: Class C Common Stock · 28,252 shares

Expires 2028-11-30

F7 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F7 · shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F7 · price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F7 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F7 · balance_after: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

SEC source: 0001493152-21-026009 · ownership.xml · derivative · entry 4

Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,665

Underlying: Class C Common Stock · 29,665 shares

Expires 2028-11-30

F4 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F4 · shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F4 · price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F4 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F4 · balance_after: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

SEC source: 0001493152-22-003299 · ownership.xml · derivative · entry 5

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat'l Marketing Dir/Life

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,252

Underlying: Class C Common Stock · 28,252 shares

Expires 2028-11-30

F5 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F5 · shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F5 · price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F5 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F5 · balance_after: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

SEC source: 0001096906-23-001422 · form4.xml · derivative · entry 5

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mark Dir of Life Ins

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,314

Underlying: Class C Common Stock · 32,705 shares

Expires 2028-11-30

F4 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019 and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 08, 2022, and July 14, 2023.

SEC source: 0001096906-23-002418 · form4.xml · derivative · entry 4

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mark Dir of Life Ins

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,314

Underlying: Class C Common Stock · 32,705 shares

Expires 2028-11-30

F4 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019 and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 08, 2022, and July 14, 2023.

SEC source: 0001096906-24-001949 · primary_doc.xml · derivative · entry 6

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mark Dir of Life Ins

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,476

Underlying: Class C Common Stock · 34,340 shares

Expires 2028-11-30

F5 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019 and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 08, 2022, July 14, 2023 and July 12, 2024.

SEC source: 0001096906-24-002045 · form4.xml · derivative · entry 5

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mark Dir of Life Ins

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,187

Underlying: Class C Common Stock · 34,340 shares

Expires 2028-11-30

F4 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019 and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023 and July 12, 2024.

SEC source: 0001096906-24-002312 · form4.xml · derivative · entry 2

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mark Dir of Life Ins · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,187

Underlying: Class C Common Stock · 34,340 shares

Expires 2028-11-30

F2 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019 and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023 and July 12, 2024.

SEC source: 0001096906-25-000172 · form4.xml · derivative · entry 4

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mark Dir of Life Ins · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Common Stock · 34,340 shares

Expires 2028-11-30

F4 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019 and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023 and July 12, 2024.

SEC source: 0001096906-18-000375 · primary_doc.xml · nonDerivative · entry 2

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,880

F2 · balance_after: Does not include 86,629 shares of Class A Common Stock owned individually by the reporting person in the 401(k) Retirement Savings Plan and the Deferred Compensation Plan.

SEC source: 0001096906-18-000375 · primary_doc.xml · nonDerivative · entry 1

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,880

F1 · kind: Received pursuant to a stock dividend paid on February 2, 2018.

F2 · balance_after: Does not include 86,629 shares of Class A Common Stock owned individually by the reporting person in the 401(k) Retirement Savings Plan and the Deferred Compensation Plan.

SEC source: 0001096906-17-000789 · primary_doc.xml · derivative · entry 6

Overbaugh Jason G. · CIK 0001588310 · Director · VP and Nat'l Marketing Dir. LI

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Class C Common Stock · 20,000 shares

Expires 2027-12-01

F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person s election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option vests in four equal quarterly installments of Class C Common Stock, beginning on March 1, 2018, until such shares are fully vested.

F6 · shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person s election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option vests in four equal quarterly installments of Class C Common Stock, beginning on March 1, 2018, until such shares are fully vested.

F6 · price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person s election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option vests in four equal quarterly installments of Class C Common Stock, beginning on March 1, 2018, until such shares are fully vested.

F6 · derivative.exercise_date: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person s election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option vests in four equal quarterly installments of Class C Common Stock, beginning on March 1, 2018, until such shares are fully vested.

F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person s election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option vests in four equal quarterly installments of Class C Common Stock, beginning on March 1, 2018, until such shares are fully vested.

F6 · balance_after: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person s election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option vests in four equal quarterly installments of Class C Common Stock, beginning on March 1, 2018, until such shares are fully vested.

SEC source: 0001096906-18-000375 · primary_doc.xml · derivative · entry 8

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,000

Underlying: Class C Common Stock · 21,000 shares

Expires 2027-12-01

F8 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option vests in four equal quarterly installments of Class C Common Stock, beginning on March 1, 2018, until such shares are fully vested, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018.

F8 · shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option vests in four equal quarterly installments of Class C Common Stock, beginning on March 1, 2018, until such shares are fully vested, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018.

F8 · price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option vests in four equal quarterly installments of Class C Common Stock, beginning on March 1, 2018, until such shares are fully vested, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018.

F8 · derivative.exercise_date: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option vests in four equal quarterly installments of Class C Common Stock, beginning on March 1, 2018, until such shares are fully vested, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018.

F8 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option vests in four equal quarterly installments of Class C Common Stock, beginning on March 1, 2018, until such shares are fully vested, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018.

F8 · balance_after: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option vests in four equal quarterly installments of Class C Common Stock, beginning on March 1, 2018, until such shares are fully vested, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018.

SEC source: 0001096906-18-000701 · primary_doc.xml · derivative · entry 6

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,000

Underlying: Class C Common Stock · 21,000 shares

Expires 2027-12-01

F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018.

F6 · shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018.

F6 · price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018.

F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018.

F6 · balance_after: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018. This option is fully vested on December 1, 2018.

SEC source: 0001096906-19-000079 · primary_doc.xml · derivative · entry 7

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,050

Underlying: Class C Common Stock · 22,050 shares

Expires 2027-12-01

F8 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019.

F8 · shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019.

F8 · price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019.

F8 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019.

F8 · balance_after: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019.

SEC source: 0001096906-19-000433 · primary_doc.xml · derivative · entry 6

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,050

Underlying: Class C Common Stock · 22,050 shares

Expires 2027-12-01

F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019.

F6 · shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019.

F6 · price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019.

F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019.

F6 · balance_after: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019.

SEC source: 0001096906-20-000010 · primary_doc.xml · derivative · entry 11

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,050

Underlying: Class C Common Stock · 22,050 shares

Expires 2027-12-01

F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019.

F6 · shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019.

F6 · price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019.

F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019.

F6 · balance_after: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018 and February 1, 2019.

SEC source: 0001445866-20-000844 · primary_doc.xml · derivative · entry 5

Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,153

Underlying: Class C Common Stock · 23,153 shares

Expires 2027-12-01

F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020.

F6 · shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020.

F6 · price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020.

F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020.

F6 · balance_after: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020.

SEC source: 0001445866-20-001119 · primary_doc.xml · derivative · entry 5

Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,732

Underlying: Class C Common Stock · 23,732 shares

Expires 2027-12-01

F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F6 · shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F6 · price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F6 · balance_after: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

SEC source: 0001096906-21-000039 · form4.xml · derivative · entry 5

Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Mkting Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,732

Underlying: Class C Common Stock · 23,732 shares

Expires 2027-12-01

F5 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F5 · shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F5 · price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F5 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F5 · balance_after: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

SEC source: 0001096906-21-002161 · primary_doc.xml · derivative · entry 4

Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,574

Underlying: Class C Common Stock · 22,574 shares

Expires 2027-12-01

F4 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F4 · shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F4 · price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F4 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F4 · balance_after: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

SEC source: 0001096906-21-002160 · primary_doc.xml · derivative · entry 7

Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,574

Underlying: Class C Common Stock · 22,574 shares

Expires 2027-12-01

F6 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F6 · shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F6 · price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F6 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F6 · balance_after: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

SEC source: 0001493152-21-026009 · ownership.xml · derivative · entry 3

Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,919

Underlying: Class C Common Stock · 24,919 shares

Expires 2027-12-01

F3 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F3 · shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F3 · price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F3 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F3 · balance_after: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

SEC source: 0001493152-22-003299 · ownership.xml · derivative · entry 4

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat'l Marketing Dir/Life

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,732

Underlying: Class C Common Stock · 23,732 shares

Expires 2027-12-01

F4 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F4 · shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F4 · price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F4 · derivative.underlying_shares: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F4 · balance_after: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

SEC source: 0001096906-23-001422 · form4.xml · derivative · entry 4

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mark Dir of Life Ins

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,609

Underlying: Class C Common Stock · 27,473 shares

Expires 2027-12-01

F3 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.05 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 08, 2022. and July 14, 2023.

SEC source: 0001096906-23-002418 · form4.xml · derivative · entry 3

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mark Dir of Life Ins

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,609

Underlying: Class C Common Stock · 27,473 shares

Expires 2027-12-01

F3 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 08, 2022. and July 14, 2023.

SEC source: 0001096906-24-001949 · primary_doc.xml · derivative · entry 5

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mark Dir of Life Ins

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,136

Underlying: Class C Common Stock · 28,847 shares

Expires 2027-12-01

F4 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 08, 2022, July 14, 2023 and July 12, 2024.

SEC source: 0001096906-24-002045 · form4.xml · derivative · entry 4

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mark Dir of Life Ins

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,847

Underlying: Class C Common Stock · 28,847 shares

Expires 2027-12-01

F3 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023 and July 12, 2024.

SEC source: 0001096906-24-002312 · form4.xml · derivative · entry 1

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mark Dir of Life Ins · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,847

Underlying: Class C Common Stock · 28,847 shares

Expires 2027-12-01

F1 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023 and July 12, 2024.

SEC source: 0001096906-25-000172 · form4.xml · derivative · entry 3

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mark Dir of Life Ins · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Common Stock · 28,847 shares

Expires 2027-12-01

F3 · derivative.exercise_price: This option was granted on December 1, 2017 as an option to purchase either 20,000 shares of Class A Common Stock or 20,000 shares of Class C Common Stock at an exercise price of $5.05 per share. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023 and July 12, 2024.

SEC source: 0001096906-17-000275 · primary_doc.xml · nonDerivative · entry 2

Overbaugh Jason G. · CIK 0001588310 · Director · VP; Nat. Mrkt. Dir Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,282

F1 · kind: Received pursuant to a stock dividend paid on February 3, 2017.

F2 · balance_after: Does not include 75,455 shares of Class A Common Stock owned indirectly by the reporting person in the 401(k) Retirement Savings Account and the Deferred Compensation Plan.

SEC source: 0001096906-17-000275 · primary_doc.xml · nonDerivative · entry 1

Overbaugh Jason G. · CIK 0001588310 · Director · VP; Nat. Mrkt. Dir Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,935

F2 · balance_after: Does not include 75,455 shares of Class A Common Stock owned indirectly by the reporting person in the 401(k) Retirement Savings Account and the Deferred Compensation Plan.

SEC source: 0001096906-16-002098 · primary_doc.xml · derivative · entry 5

Overbaugh Jason G. · CIK 0001588310 · Director · VP and Nat'l Marketing Dir. LI

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Class A Common Stock · 20,000 shares

Expires 2026-12-02

F5 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 2, 2017, until such shares are fully vested.

F5 · shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 2, 2017, until such shares are fully vested.

F5 · price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 2, 2017, until such shares are fully vested.

F5 · derivative.exercise_date: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 2, 2017, until such shares are fully vested.

F5 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 2, 2017, until such shares are fully vested.

F5 · balance_after: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 2, 2017, until such shares are fully vested.

SEC source: 0001096906-17-000275 · primary_doc.xml · derivative · entry 7

Overbaugh Jason G. · CIK 0001588310 · Director · VP; Nat. Mrkt. Dir Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,000

Underlying: Class A Common Stock · 21,000 shares

Expires 2026-12-02

F7 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 3, 2017. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 2, 2017, until such shares are fully vested.

F7 · shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 3, 2017. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 2, 2017, until such shares are fully vested.

F7 · price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 3, 2017. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 2, 2017, until such shares are fully vested.

F7 · derivative.exercise_date: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 3, 2017. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 2, 2017, until such shares are fully vested.

F7 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 3, 2017. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 2, 2017, until such shares are fully vested.

F7 · balance_after: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 3, 2017. This option vests in four equal quarterly installments of Class A Common Stock, beginning on March 2, 2017, until such shares are fully vested.

SEC source: 0001096906-17-000789 · primary_doc.xml · derivative · entry 5

Overbaugh Jason G. · CIK 0001588310 · Director · VP and Nat'l Marketing Dir. LI

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,000

Underlying: Class A Common Stock · 21,000 shares

Expires 2026-12-02

F5 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 3, 2017.

F5 · shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 3, 2017.

F5 · price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 3, 2017.

F5 · derivative.exercise_date: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 3, 2017.

F5 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 3, 2017.

F5 · balance_after: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 3, 2017.

SEC source: 0001096906-18-000375 · primary_doc.xml · derivative · entry 7

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,050

Underlying: Class A Common Stock · 22,050 shares

Expires 2026-12-02

F7 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017 and February 2, 2018.

F7 · shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017 and February 2, 2018.

F7 · price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017 and February 2, 2018.

F7 · derivative.exercise_date: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017 and February 2, 2018.

F7 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017 and February 2, 2018.

F7 · balance_after: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017 and February 2, 2018.

SEC source: 0001096906-18-000701 · primary_doc.xml · derivative · entry 5

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,050

Underlying: Class A Common Stock · 22,050 shares

Expires 2026-12-02

F5 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017 and February 2, 2018.

F5 · shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017 and February 2, 2018.

F5 · price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017 and February 2, 2018.

F5 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017 and February 2, 2018.

F5 · balance_after: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017 and February 2, 2018.

SEC source: 0001096906-19-000079 · primary_doc.xml · derivative · entry 6

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,153

Underlying: Class A Common Stock · 23,153 shares

Expires 2026-12-02

F7 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019.

F7 · shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019.

F7 · price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019.

F7 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019.

F7 · balance_after: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019.

SEC source: 0001096906-19-000433 · primary_doc.xml · derivative · entry 5

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,153

Underlying: Class A Common Stock · 23,153 shares

Expires 2026-12-02

F5 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019.

F5 · shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019.

F5 · price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019.

F5 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019.

F5 · balance_after: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019.

SEC source: 0001096906-20-000010 · primary_doc.xml · derivative · entry 10

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,153

Underlying: Class A Common Stock · 23,153 shares

Expires 2026-12-02

F5 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019.

F5 · shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019.

F5 · price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019.

F5 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019.

F5 · balance_after: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, and February 1, 2019.

SEC source: 0001445866-20-000844 · primary_doc.xml · derivative · entry 4

Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,311

Underlying: Class A Common Stock · 24,311 shares

Expires 2026-12-02

F5 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020.

F5 · shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020.

F5 · price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020.

F5 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020.

F5 · balance_after: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020.

SEC source: 0001445866-20-001119 · primary_doc.xml · derivative · entry 4

Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,919

Underlying: Class A Common Stock · 24,919 shares

Expires 2026-12-02

F5 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F5 · shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F5 · price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F5 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F5 · balance_after: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

SEC source: 0001096906-21-000039 · form4.xml · derivative · entry 4

Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Mkting Dir of Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,919

Underlying: Class A Common Stock · 24,919 shares

Expires 2026-12-02

F4 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F4 · shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F4 · price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F4 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

F4 · balance_after: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; and a 2 1/2% stock dividend paid on July 17, 2020.

SEC source: 0001096906-21-002161 · primary_doc.xml · derivative · entry 3

Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,919

Underlying: Class A Common Stock · 24,919 shares

Expires 2026-12-02

F3 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F3 · shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F3 · price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F3 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F3 · balance_after: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

SEC source: 0001096906-21-002160 · primary_doc.xml · derivative · entry 6

Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,919

Underlying: Class A Common Stock · 24,919 shares

Expires 2026-12-02

F5 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F5 · shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F5 · price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F5 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F5 · balance_after: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

SEC source: 0001493152-21-026009 · ownership.xml · derivative · entry 2

Overbaugh Jason G. · CIK 0001588310 · Director · VP/Ntnl Marketing Dir-Life Ins

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,165

Underlying: Class A Common Stock · 26,165 shares

Expires 2026-12-02

F2 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F2 · shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F2 · price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F2 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F2 · balance_after: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

SEC source: 0001493152-22-003299 · ownership.xml · derivative · entry 3

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat'l Marketing Dir/Life

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,919

Underlying: Class A Common Stock · 24,919 shares

Expires 2026-12-02

F3 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F3 · shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F3 · price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F3 · derivative.underlying_shares: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

F3 · balance_after: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020, a 2 1/2% stock dividend paid on July 17, 2020, and a 5% stock dividend paid on July 16, 2021.

SEC source: 0001096906-23-001422 · form4.xml · derivative · entry 3

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mark Dir of Life Ins

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,136

Underlying: Class A Common Stock · 28,847 shares

Expires 2026-12-02

F2 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 08, 2022, and July 14, 2023.

SEC source: 0001096906-23-002418 · form4.xml · derivative · entry 2

Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mark Dir of Life Ins

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,136

Underlying: Class A Common Stock · 28,847 shares

Expires 2026-12-02

F2 · derivative.exercise_price: This option was granted on December 2, 2016 as an option to purchase 20,000 shares of Class A Common Stock at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; a 2 1/2% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 08, 2022, and July 14, 2023.